NCT00109759View on ClinicalTrials.gov

Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2005

Study Completion Date

June 30, 2005

Conditions
Type I Hypersensitivity
Interventions
BIOLOGICAL

RagweedMATAMPL

DRUG

Placebo

Trial Locations (1)

L4W 1N2

Allied Research International Inc., Mississauga

Sponsors
All Listed Sponsors
lead

Allergy Therapeutics

INDUSTRY